Bridgewater Just Sold Salesforce: A Patient-Stock Debate
Bridgewater Associates exits its Salesforce stake, prompting a broader discussion on how patient capital should value...
Discover the best sources for free retirement planning tools. Equip yourself with the right resources for effective planning.
19,631 articlesBridgewater Associates exits its Salesforce stake, prompting a broader discussion on how patient capital should value...
MSCI stock is facing a sharp move lower after quarterly results and an strategic shift. This article explains the dri...
Nvidia has delivered one of the era's most dramatic stock ascents. But with such gains already in the price, can the ...
A high-conviction AI stock has turned heads as it climbs on stronger demand for AI infrastructure and software. This ...
An almost 12% jump in lantheus holdings stock popped last month left investors asking what lit the fuse. This article...
CrowdStrike has become a pillar in AI-era cybersecurity, but a 14% decline raises the question: is it a buy? This gui...
IBM has delivered a multiyear rally, but a 2026 pullback creates a buying opportunity for patient investors. This gui...
ServiceNow is rolling out an AI-driven strategy that aims to turn it into a central control tower for enterprise work...
Cyber threats keep evolving, and investors are eyeing cybersecurity leaders. This guide breaks down whether palo alto...
Is Palantir stock undervalued stock? This in-depth guide breaks down the AI growth case, valuation angles, and how to...
Titan America (TTAM) is shaping investor expectations in 2026 as Q1 results roll in. This deep dive translates earnin...
Investors weigh AI infrastructure costs against Azure growth as Microsoft and tech peers face margin pressure. Here’s...